Defective Molecular Timer in the Absence of Nucleotides Leads to Inefficient Caspase Activation

• Honghao Zhang,

  Affiliation Department of Pharmacology and Therapeutics, Roswell Park Cancer Institute, Buffalo, New York, United States of America

  ⨯
• Raghu Gogada,

  Affiliation Department of Pharmacology and Therapeutics, Roswell Park Cancer Institute, Buffalo, New York, United States of America

  ⨯
• Neelu Yadav,

  Affiliation Department of Pharmacology and Therapeutics, Roswell Park Cancer Institute, Buffalo, New York, United States of America

  ⨯
• Ravi K. Lella,

  Affiliation Department of Pharmacology and Therapeutics, Roswell Park Cancer Institute, Buffalo, New York, United States of America

  ⨯
• Mark Badeaux,

  Affiliation Department of Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Smithville, Texas, United States of America

  ⨯
• Mary Ayres,

  Affiliation Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America

  ⨯
• Varsha Gandhi,

  Affiliation Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America

  ⨯
• Dean G. Tang,

  Affiliation Department of Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Smithville, Texas, United States of America

  ⨯
• Dhyan Chandra

  * E-mail: dhyan.chandra@roswellpark.org

  Affiliation Department of Pharmacology and Therapeutics, Roswell Park Cancer Institute, Buffalo, New York, United States of America

  ⨯